Risk Analysis System and Risk Analysis Method
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application PCT/JP2017/023511, filed Jun 27, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,087,406 | Risk Analysis System and Risk Analysis Method In force · High confidence | Omron Healthcare Co., Ltd. and Omron Corporation | In force | High confidence | ||
| US 11,734,768 | Risk Analysis System and Risk Analysis Method In force · Medium confidence | Omron Healthcare Co., Ltd. and Omron Corporation | In force | Medium confidence | ||
| US 11,769,208 | Risk Analysis System and Risk Analysis Method In force · Medium confidence | Omron Healthcare Co., Ltd. and Omron Corporation | In force | Medium confidence | ||
| US 11,776,063 | Risk Analysis System and Risk Analysis Method In force · Medium confidence | Omron Healthcare Co., Ltd. and Omron Corporation | In force | Medium confidence |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.